title: Drug-induced pulmonary disease. An update.
authors.affiliation: Division of Thoracic Diseases, Mayo Clinic, Rochester, Minn.
authors.forename: E C
authors.initials: EC
authors.lastname: Rosenow
authors.forename: J L
authors.initials: JL
authors.lastname: Myers
authors.forename: S J
authors.initials: SJ
authors.lastname: Swensen
authors.forename: R J
authors.initials: RJ
authors.lastname: Pisani
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001986:Bronchial Spasm / Q000139:chemically induced; D002317:Cardiovascular Agents / Q000009:adverse effects; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D008171:Lung Diseases / Q000139:chemically induced*; D010996:Pleural Effusion / Q000139:chemically induced
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D013287:Illicit Drugs